Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Analysis of several characteristics of blood from pregnant women with CMV infection according to maternal-fetal transmission. These include CMV viral load, cytokine profile in response to in-vitro stimulation with CMV peptides, meticulous analysis of anti CMV antibodies, maternal DNA polymorphism and microarray of gene expression.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection

NCT01081379

Pregnant Women Cytomegalovirus Infections

UNKNOWN

Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

NCT01251744

Infections, Cytomegalovirus Cytomegalovirus Infections

COMPLETED NA

Biomarkers of Cytomegalovirus Fetal Infection and Disease

NCT03090841

Cytomegalovirus Congenital

UNKNOWN

Cytomegalovirus (CMV) Infection in Pregnancy

NCT00194155

Pregnancy Complications Cytomegalovirus Infection

COMPLETED

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients

NCT00699868

Cytomegalovirus Infection

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Maternal Cytomegalovirus infection in pregnancy may cause significant morbidity in the fetus. Intrauterine CMV transmission occurs mainly during primary maternal infections, with a maternal-fetal transmission rate of about 40%. The mechanisms dictating CMV intrauterine transmission are unknown, and transmission is currently thought to be dependent on multiple factors, including the maternal and fetal immune system.

To investigate the mechanism of transmission approaching laboratory prediction of transmission, the investigators collect blood from pregnant women with primary CMV infection, and analyze several characteristics. These include CMV viral load, cytokine profile in response to in-vitro stimulation with CMV peptides, meticulous analysis of anti CMV antibodies, maternal DNA polymorphism and microarray of gene expression.

These results will be analysed according to transmission as indicated by a positive culture / Polymerase chain transcription of amniotic fluid or newborns urine / saliva.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Cytomegalovirus Infections Congenital Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant women
* CMV infection: primary infection: (1) CMV-specific IgG seroconversion or (2) demonstration of low avidity CMV-specific IgG antibodies, (3) the primary appearance of CMV-specific IgM with no previous IgG, and (4) CMV DNA or viral products in blood Secondary infection: appearance of CMV-specific IgM with positive IgG